Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Pharmaceutical composition for treating osteoproliferation and preparation method of pharmaceutical composition

A bone hyperplasia and composition technology, which is applied in the direction of drug combination, pharmaceutical formula, medical preparations containing active ingredients, etc., can solve the problems that it cannot be used as a treatment for bone hyperplasia

Inactive Publication Date: 2017-06-13
JINAN HAOYU QINGTIAN PHARMA TECH CO LTD
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Therefore, for mild bone hyperplasia and severe bone hyperplasia, acupuncture and moxibustion therapy has a good effect, but it still cannot be used as the primary treatment for bone hyperplasia.
Massage therapy is roughly the same as acupuncture therapy, which can also relieve pain, promote blood circulation and remove blood stasis, but it is still not the first choice for bone hyperplasia treatment

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0037] Embodiment 1: the pharmaceutical composition for the treatment of hyperosteogeny and preparation method thereof

[0038] The composition and parts by weight of the crude drug of the pharmaceutical composition for treating hyperosteogeny are: garcinia biflavone 30g, Guangxi dog's tooth flower 470g, scutellaria 327g, cosmolide 9g, anisodine 5g, lycopine 1.5g;

[0039] Preparation:

[0040] (1) According to the ratio of raw materials, take gamboge amiflavone, Guangxi dog tooth flower, flutter grass, woody hydrocarbon lactone, anisodine, lycopine, mix well, and use ethanol with a concentration of 25% by weight as a solvent, Warm soaking and extracting at 38°C, the number of extractions is 11 times, and the extraction time is 34 hours each time, and the amount of solvent used each time is 48 times the total weight of the raw material drug, and filtered to obtain medicinal residue A and extract A, and the extract A is recovered Ethanol, concentrated to a relative density of ...

Embodiment 2

[0043] Embodiment 2: the pharmaceutical composition for the treatment of hyperosteogeny and preparation method thereof

[0044] The composition and parts by weight of the crude drug of the pharmaceutical composition for treating hyperosteogeny are: garcinia biflavone 25g, Guangxi Bermudagrass 480g, scutellaria 326g, cosmolide 10g, anisodine 4g, lycopine 2g;

[0045] Preparation:

[0046] (1) According to the ratio of raw materials, take gamboge amiflavone, Guangxi dog tooth flower, flutter grass, woody hydrocarbon lactone, anisodine, lycopine, mix well, and use ethanol with a concentration of 25% by weight as a solvent, Warm soaking and extracting at 38°C, the number of extractions is 11 times, and the extraction time is 34 hours each time, and the amount of solvent used each time is 48 times the total weight of the raw material drug, and filtered to obtain medicinal residue A and extract A, and the extract A is recovered Ethanol, concentrated to a relative density of 1.18, f...

Embodiment 3

[0049] Embodiment 3: the pharmaceutical composition for the treatment of hyperosteogeny and preparation method thereof

[0050] The composition and parts by weight of the crude drug of the pharmaceutical composition for treating hyperosteogeny are: garcinia biflavone 35g, Guangxi dog's teeth flower 460g, scutellaria 328g, corylidene 8g, anisodine 6g, lycopine 1g;

[0051] Preparation:

[0052] (1) According to the ratio of raw materials, take gamboge amiflavone, Guangxi dog tooth flower, flutter grass, woody hydrocarbon lactone, anisodine, lycopine, mix well, and use ethanol with a concentration of 25% by weight as a solvent, Warm soaking and extracting at 38°C, the number of extractions is 11 times, and the extraction time is 34 hours each time, and the amount of solvent used each time is 48 times the total weight of the raw material drug, and filtered to obtain medicinal residue A and extract A, and the extract A is recovered Ethanol, concentrated to a relative density of 1...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a pharmaceutical composition for treating hyperosteogeny and a preparation method thereof. The pharmaceutical composition of the invention is composed of garcinia biflavone, Guangxi bermudagrass, flicker grass, woody hydrocarbon lactone, anisodine, Lycoperionine is the raw material medicine, which is prepared in proportion, and can be made into various dosage forms according to the conventional preparation process, and has remarkable curative effect in treating hyperosteogeny.

Description

technical field [0001] The invention belongs to the technical field of traditional Chinese medicines, and in particular relates to a pharmaceutical composition for treating hyperosteogeny and a preparation method thereof. Background technique [0002] Osteoarthritis, commonly known as bone spur, is a disease often suffered by middle-aged and elderly people. It is mainly a common physiological phenomenon caused by the aging of the joints of elderly patients. The older the patient, the higher the prevalence rate. In China, the aggravation of the aging society has led to an increase in the prevalence of the disease year by year. During the onset period, patients with hyperosteogeny mainly manifest as pain and numbness in the joints, which seriously affect the daily life of patients with hyperosteogeny. The essence of osteoproliferative lesions is due to specific lesions on the articular surface or edges. The proliferative bone spurs compress the surrounding soft tissues, nerv...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/89A61P19/08A61K36/24A61K31/352A61K31/365A61K31/439A61K31/4375
CPCA61K36/24A61K31/352A61K31/365A61K31/4375A61K31/439A61K36/89A61K2236/333A61K2236/39A61K2236/51A61K2236/55
Inventor 不公告发明人
Owner JINAN HAOYU QINGTIAN PHARMA TECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com